<?xml version="1.0" encoding="UTF-8"?>
<p>Donor/recipient CMV serostatus is an important determinant of the risk of CMV infection after allogeneic HSCT. Leaving apart D
 <sup>–</sup>/R
 <sup>–</sup> recipients, the risk increases steeply from D
 <sup>+</sup>/R
 <sup>–</sup> to D
 <sup>+</sup>/R
 <sup>+</sup>, with the highest risk for D
 <sup>–</sup>/R
 <sup>+</sup> transplantations [
 <xref rid="CIT0007" ref-type="bibr">7</xref>]. The study by Zhao et al was limited to concordant seropositive donor/recipient pairs, thus a high-risk group.
</p>
